Hospitals in Nottingham are set to introduce a "ground-breaking" new artificial intelligence tool to help speed up breast cancer diagnosis. Nottingham University Hospitals (NUH), which runs City Hospital and Queen's Medical Centre, is one of five NHS trusts in England and Wales in a £100 million consortium that will use the technology, which could potentially save lives.
The tech helps pathologists identify more than 50 breast-specific features and has the potential to reduce the turnaround time for patients. NUH pathologists will evaluate the technology’s impact on the quality of diagnosis, case review time and cost-effectiveness of breast cancer diagnosis.
Professor Emad Rakha, honorary consultant pathologist at the University of Nottingham and NUH, said the AI could "significantly impact breast cancer survival rates". He said: “Over the last several years in the UK, cancer cases increased while the number of pathologists decreased, resulting in record-high workloads for pathology departments.
